Full-Time

Key Account Manager

Oncology / Solid Tumour

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

No salary listed

Senior

Newcastle upon Tyne, UK + 2 more

More locations: Scotland, UK | Northern Ireland, UK

Category
Strategic Account Management
Sales & Account Management
Requirements
  • Degree in scientific or business-related subject or equivalent qualification.
  • ABPI qualified.
  • 5+ years successful industry sales experience
  • Clean driving licence
  • Sound understanding of UK pharmaceutical industry and demonstrates a comprehensive understanding of NHS policies, structures, funding streams and processes relevant to promoted products
  • Responsibility for managing customer relationships across the full spectrum of customer types, including population decision makers within the local health economy, to achieve sales targets.
  • Exceptional business planning and account management skills
  • High level of influencing and negotiation skills
  • Demonstrates well developed business and commercial acumen
  • Ability to assimilate and communicate complex clinical data
  • Proactive and accountable with a clear drive for completion and delivery
Responsibilities
  • Develop the regional business plan and financial objectives, supporting and reflecting central strategy.
  • Lead the delivery of the business plan working in collaboration with other Takeda functions.
  • Align business objectives to relevant NHS customer needs across local health economies/networks.
  • Construct, present and agree with the Divisional Sales Director/Business Unit Director the financial objectives, promotional strategy and tactics for the Region as part of business planning process.
  • Be accountable for the delivery of the plan across the Oncology portfolio of products, working with other field teams, their line management and Takeda Head Office functions.
  • Monitor and review the regional business plan, proactively making adjustments in line with changing circumstances to ensure that business goals are achieved.
  • Leverage support for products/ideas/projects across networks and to contribute to the development and mobilisation of local and national brand advocates.
  • Work collaboratively with other Takeda field teams and Head Office functions to integrate working practices and differentiate Takeda effectively to leverage maximum value for the company and the NHS.
  • Maintain a detailed knowledge of national policy objectives/drivers and apply this to identify opportunities for growing the business at a regional level.
  • Ensure that all knowledge management and CRM systems are maintained in accordance with Takeda standards and to ensure that business plans and objectives are transparent to the Senior Leadership Team of Takeda UK.
  • Possess a thorough understanding of the provisions of the APBI Code of Practice and Takeda SOPs, to ensure that the Company’s image and reputation is never jeopardised by irresponsible or unethical conduct.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.